The authors also suggest that tesofensine may have a lesser impact on blood pressure and heart rate compared to sibutramine, despite achieving similar weight loss
Phase 3 (Week 9 and beyond): For patients who need additional effect, the 12 mg/0.1 mg tablet is available
Tirzepatide is an advanced, dual-action injectable medication originally developed for type 2 diabetes now also used to support significant weight loss
[DOI] [PubMed] [Google Scholar] 96.Azzam OA, Leheta TM, Nagui NA, Shaarawy E, Hay RM, Hilal RF
Choline is essential for fat metabolism and liver function
Diabetic patients showed an even greater risk reduction of 41%